Skip to content
value.today
InspireMD, Inc. logo

InspireMD, Inc.

Total raised
$2 M
1 round on record
Latest round
$2 M
Mar 2011
First round on record
Mar 2011
Today
Went public
See the company page

InspireMD, Inc. is listed today as InspireMD, Inc.: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding, 5 other private sales on record. Open the number of investors for the round's details.

Funding rounds of InspireMD, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2025$40 MPrivate placement after listing$10 to $50 million

InspireMD, Inc.: Private sale, Jul 2025

Investors in this round

18 investors had bought by the notice of Aug 4, 2025: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$40 M of $40 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Shares of Common Stock & Warrants, including underlying common stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,388,900
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrea Tommasoli · Executive Officer · Chief Operating Officer
  • Marvin Slosman · Executive Officer, Director · President and Chief Executive Officer
  • Mike Lawless · Executive Officer · Chief Financial Officer
  • Patrick Verta · Executive Officer
  • Pete Ligotti · Executive Officer
  • Shane Gleason · Executive Officer
  • Gary J. Roubin, M.D. · Director
  • Kathryn J. Arnold · Director
  • Michael Berman · Director
  • Paul Stuka · Director
  • Raymond J. Cohen · Director
  • Scott R. Ward · Director
  • Thomas J. Kester · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • BofA Securities, Inc. (CRD 000283942) · New York, New YorkSold in all US states

Signed by Marvin Slosman, President and CEO. Source: SEC Form D, newest notice filed Aug 4, 2025. Read the notice at the SEC.

equity, optionsSEC
May 2023$42 MPrivate placement after listing$10 to $50 million

InspireMD, Inc.: Private sale, May 2023

Investors in this round

18 investors had bought by the notice of May 30, 2023: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$42 M of $42 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Shares of Common Stock, and Common Stock Purchase Warrants (Series H, I, J, K Warrants) to purchase common stock, and underlying shares of common stock upon exercise of warrants.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$4,191,600
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrea Tommasoli · Executive Officer · Chief Operating Officer
  • Craig Shore · Executive Officer · Chief Financial Officer, Secretary and Treasurer
  • Marvin Slosman · Executive Officer, Director · President and Chief Executive Officer
  • Shane Gleason · Executive Officer · General Manager of North America & VP of Global Marketing
  • Gary J. Roubin, M.D. · Director
  • Kathryn J. Arnold · Director
  • Michael Berman · Director
  • Paul Stuka · Director
  • Thomas J. Kester · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Piper Sandler & Co. (CRD 665) · Minneapolis, MinnesotaSold in all US states
  • A.G.P./Alliance Global Partners (CRD 8361) · Westport, ConnecticutSold in all US states
  • LifeSci Capital LLC (CRD 168404) · New York, New YorkSold in all US states

Remarks in the notice

  • On the amounts: “Does not include cash amount if warrants exercised in full”

Signed by Marvin Slosman, President and CEO. Source: SEC Form D, newest notice filed May 30, 2023. Read the notice at the SEC.

equity, optionsSEC
Jan 2013$3 MPrivate placement after listing$2 to $10 million

InspireMD, Inc.: Private sale, Jan 2013

Investors in this round

1 investor had bought by the notice of Jan 18, 2013: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alan W. Milinazzo · Executive Officer, Director
  • Craig W. Shore · Executive Officer
  • Eli W. Bar · Executive Officer
  • Robert W. Ratini · Executive Officer
  • Asher J. Holzer · Director
  • Eyal J. Weinstein · Director
  • James J. Barry · Director
  • James J. Loughlin · Director
  • Ofir J. Paz · Director
  • Paul J. Stuka · Director
  • Sol J. Barer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Grant of nonqualified stock option to purchase 525,927 shares of the Company?s common stock, incentive stock option to purchase 74,073 shares of common stock and 400,000 shares of restricted stock to the Company's CEO under his employment agreement.”

Signed by Craig Shore, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 18, 2013. Read the notice at the SEC.

equity, optionsSEC
Oct 2012$2 MPrivate placement after listingUnder $2 million

InspireMD, Inc.: Private sale, Oct 2012

Investors in this round

1 investor had bought by the notice of Nov 2, 2012: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Craig Shore · Executive Officer
  • Eli Bar · Executive Officer
  • Ofir Paz · Executive Officer, Director
  • Robert Ratini · Executive Officer
  • Asher J. Holzer · Director
  • Eyal J. Weinstein · Director
  • James J. Barry · Director
  • James J. Loughlin · Director
  • Paul J. Stuka · Director
  • Sol J. Barer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Shares granted to licensor in consideration of amendment to license agreement.”

Signed by Craig Shore, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 2, 2012. Read the notice at the SEC.

equitySEC
Apr 2012$11 MPrivate placement after listing$10 to $50 million

InspireMD, Inc.: Private sale, Apr 2012

Investors in this round

6 investors had bought by the notice of Apr 18, 2012: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $11 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$848,750
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Asher Holzer · Executive Officer, Director
  • Craig Shore · Executive Officer
  • Ofir Paz · Executive Officer, Director
  • Eyal Weinstein · Director
  • James Barry · Director
  • Paul Stuka · Director
  • Sol Barer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Palladium Capital Advisors, LLC (CRD 129400) · broker-dealer Palladium Capital Advisors, LLC (CRD 129400) · New York, New YorkSold in NY
  • OPPENHEIMER & CO. INC. (CRD 249) · broker-dealer OPPENHEIMER & CO. INC. (CRD 249) · New York, New YorkSold in CA
  • JMP SECURITIES LLC (CRD 22208) · broker-dealer JMP SECURITIES LLC (CRD 22208) · San Francisco, CaliforniaSold in CA

Remarks in the notice

  • On the amounts: “The company issued convertible promissory notes in the aggregate principal amount of $11,702,128 with an original issue discount of 6%, resulting in aggregate gross proceeds to the company of $11,000,000.”

Signed by Craig Shore, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 18, 2012. Read the notice at the SEC.

debt, optionsSEC
Mar 2011$2 MNo. 1Under $2 million

InspireMD, Inc.: Raise no. 1, Mar 2011

Investors in this round

3 investors had bought by the notice of Aug 26, 2011: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Asher Holzer · Executive Officer, Director
  • Craig Shore · Executive Officer
  • Ofir Paz · Executive Officer, Director
  • Eyal J Weinstein · Director
  • Paul J Stuka · Director
  • Sol J Barer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Craig Shore, Chief Financial Officer. Source: SEC Form D and 2 amendments, newest notice filed Aug 26, 2011. Read the notice at the SEC.

optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • InspireMD, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2025).

    SEC Form D · Aug 2025

  • The industry group it chose in its notices: Other.

    SEC Form D · Aug 2025

That is all the official record says: InspireMD, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of InspireMD, Inc. are on record.

Investors#

No investor of InspireMD, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 3 investors.

Largest shareholders today

Institutions holding InspireMD, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by InspireMD, Inc.
NameRoleNamed in
Andrea TommasoliChief Operating OfficerAug 2025
Marvin SlosmanPresident and Chief Executive OfficerAug 2025
Mike LawlessChief Financial OfficerAug 2025
Patrick VertaExecutive officerAug 2025
Pete LigottiExecutive officerAug 2025
Shane GleasonExecutive officerAug 2025
Craig ShoreChief Financial Officer, Secretary and TreasurerMay 2023
Alan W. MilinazzoExecutive officerJan 2013
Craig W. ShoreExecutive officerJan 2013
Eli W. BarExecutive officerJan 2013
Robert W. RatiniExecutive officerJan 2013
Eli BarExecutive officerNov 2012
Ofir PazExecutive officerNov 2012
Robert RatiniExecutive officerNov 2012
Asher HolzerExecutive officerApr 2012
Gary J. Roubin, M.D.DirectorAug 2025
Kathryn J. ArnoldDirectorAug 2025
Marvin SlosmanPresident and Chief Executive OfficerAug 2025
Michael BermanDirectorAug 2025
Paul StukaDirectorAug 2025
Raymond J. CohenDirectorAug 2025
Scott R. WardDirectorAug 2025
Thomas J. KesterDirectorAug 2025
Alan W. MilinazzoDirectorJan 2013
Asher J. HolzerDirectorJan 2013
Eyal J. WeinsteinDirectorJan 2013
James J. BarryDirectorJan 2013
James J. LoughlinDirectorJan 2013
Ofir J. PazDirectorJan 2013
Paul J. StukaDirectorJan 2013
Sol J. BarerDirectorJan 2013
Ofir PazDirectorNov 2012
Asher HolzerDirectorApr 2012
Eyal WeinsteinDirectorApr 2012
James BarryDirectorApr 2012
Sol BarerDirectorApr 2012
Eyal J WeinsteinDirectorAug 2011
Paul J StukaDirectorAug 2011
Sol J BarerDirectorAug 2011

Went public since 2011. Its SEC number is that of a company listed on a stock exchange.